Key Market Indicators
New Zealand's diagnostic reagent export is projected to reach nearly $12 million in 2026, up from $11 million in 2021. This represents an average annual growth rate of 1.9%. Since 1994, the country's supply has risen 8.6% each year. Serbia was ahead of New Zealand in 2021 with $11 million, while Germany, the Netherlands and the United Kingdom were the top three. New Zealand's diagnostic reagent import is expected to reach $106 million in 2026, up from $94 million in 2021. This reflects an average annual growth rate of 2%. Since 1994, the country's demand has increased 6.6% annually. Kuwait was ahead of New Zealand in 2021 with $94 million, while Germany, China and the Netherlands held the top three spots.
